Recipharm AB - Strategic SWOT Analysis Review

April 2021 | 45 pages | ID: RDC7275C584CEN
GlobalData

Abstracts

Recipharm AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, and development and technology services. The company's manufacturing services include contract manufacturing of pharmaceuticals such as semi-solids, and oral liquids, solid dose, sterile products, besides clinical trial materials including APIs and other drugs. Recipharm’s development and technology services supports customers from initial product concept to the approved commercial pharmaceutical drug. It includes services such as raw material supply, formulation, validated analytical methods, among others. The company operates in the UK, Germany, Spain, Italy, Sweden, France, Portugal, India, Israel and the US. Recipharm is headquartered in Stockholm, Sweden.

Recipharm AB Key Recent Developments

Mar 02,2021: Recipharm names 2020 International Environmental Award winner
Feb 10,2021: Recipharm bolsters biologics offering
Jan 28,2021: Recipharm publishes report for the fourth quarter and full year 2020
Dec 09,2020: Recipharm invests USD 2.5 million in clinical GMP capacity for active pharmaceutical ingredients
Nov 10,2020: Recipharm invests in its pMDI valves production capacity

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Recipharm AB - Key Facts
Recipharm AB - Key Employees
Recipharm AB - Key Employee Biographies
Recipharm AB - Major Products and Services
Recipharm AB - History
Recipharm AB - Company Statement
Recipharm AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Recipharm AB - Business Description
Business Segment: ADS
Overview
Performance
Business Segment: D&L
Overview
Performance
Business Segment: MFG-S
Overview
Performance
Business Segment: MFG-SO
Overview
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: India
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Other
Performance
Geographical Segment: Portugal
Performance
Geographical Segment: Spain
Performance
Geographical Segment: Sweden
Performance
Geographical Segment: UK
Performance
Recipharm AB - Corporate Strategy
Recipharm AB - SWOT Analysis
SWOT Analysis - Overview
Recipharm AB - Strengths
Recipharm AB - Weaknesses
Recipharm AB - Opportunities
Recipharm AB - Threats
Recipharm AB - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Recipharm AB, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Mar 02, 2021: Recipharm names 2020 International Environmental Award winner
Feb 10, 2021: Recipharm bolsters biologics offering
Jan 28, 2021: Recipharm publishes report for the fourth quarter and full year 2020
Dec 09, 2020: Recipharm invests USD 2.5 million in clinical GMP capacity for active pharmaceutical ingredients
Nov 10, 2020: Recipharm invests in its pMDI valves production capacity
Nov 05, 2020: Recipharm publishes its interim report for the third quarter 2020
Oct 13, 2020: Recipharm invests EUR 2.6 million in Kaysersberg facility
Jul 27, 2020: Recipharm publishes its interim report for the second quarter 2020
Jul 13, 2020: Recipharm doubles EBIT and expects second quarter results to be stronger than analyst consensus
May 07, 2020: Recipharm publishes its interim report January-March 2020

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Recipharm AB, Key Facts
Recipharm AB, Key Employees
Recipharm AB, Key Employee Biographies
Recipharm AB, Major Products and Services
Recipharm AB, History
Recipharm AB, Other Locations
Recipharm AB, Subsidiaries
Recipharm AB, Key Competitors
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Recipharm AB, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recipharm AB, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021